Microglial dynamics and role in the healthy and diseased brain: a paradigm of functional plasticity

D Gomez-Nicola, VH Perry - The Neuroscientist, 2015 - journals.sagepub.com
The study of the dynamics and functions of microglia in the healthy and diseased brain is a
matter of intense scientific activity. The application of new techniques and new experimental …

Friends or foes: matrix metalloproteinases and their multifaceted roles in neurodegenerative diseases

M Brkic, S Balusu, C Libert… - Mediators of …, 2015 - Wiley Online Library
Neurodegeneration is a chronic progressive loss of neuronal cells leading to deterioration of
central nervous system (CNS) functionality. It has been shown that neuroinflammation …

Differential upregulation of the cannabinoid CB2 receptor in neurotoxic and inflammation-driven rat models of Parkinson's disease

RM Concannon, BN Okine, DP Finn, E Dowd - Experimental neurology, 2015 - Elsevier
The cannabinoid CB 2 receptor has recently emerged as a potential anti-inflammatory target
to break the self-sustaining cycle of neuroinflammation and neurodegeneration that is …

Metalloproteinase-9 contributes to inflammatory glia activation and nigro-striatal pathway degeneration in both mouse and monkey models of 1-methyl-4-phenyl-1, 2 …

V Annese, MT Herrero, M Di Pentima, A Gomez… - Brain Structure and …, 2015 - Springer
Inflammation is a predominant aspect of neurodegenerative diseases, manifested by glia
activation and expression of pro-inflammatory mediators. Studies on animal models of …

Neurotoxicity effects of atrazine-induced SH-SY5Y human dopaminergic neuroblastoma cells via microglial activation

K Ma, HY Wu, B Zhang, X He, BX Li - Molecular BioSystems, 2015 - pubs.rsc.org
Atrazine (2-chloro-4-ethytlamino-6-isopropylamine-1, 3, 5-triazine; ATR) is a broad-spectrum
herbicide with a wide range of applications worldwide. However, ATR is neurotoxic; it …

The degeneration of dopaminergic synapses in Parkinson's disease: a selective animal model

I Morales, A Sanchez, C Rodriguez-Sabate… - Behavioural brain …, 2015 - Elsevier
Available evidence increasingly suggests that the degeneration of dopamine neurons in
Parkinson's disease starts in the striatal axons and synaptic terminals. A selective procedure …

Alterations of BDNF and trkB mRNA expression in the 6-hydroxydopamine-induced model of preclinical stages of Parkinson's disease: an influence of chronic …

K Berghauzen-Maciejewska, J Wardas, B Kosmowska… - PloS one, 2015 - journals.plos.org
Our recent study has indicated that a moderate lesion of the mesostriatal and mesolimbic
pathways in rats, modelling preclinical stages of Parkinson's disease, induces a depressive …

Control of macrophage dynamics as a potential therapeutic approach for clinical disorders involving chronic inflammation

W Ohashi, K Hattori, Y Hattori - Journal of Pharmacology and Experimental …, 2015 - ASPET
Macrophages are a well recognized player of both innate and adaptive immunity and have
emerged as a key regulator of systemicmetabolism, hematopoiesis, vasculogenesis …

Knockdown of interleukin-1 receptor 1 is not neuroprotective in the 6-hydroxydopamine striatal lesion rat model of Parkinson's disease

S Walsh, A Gavin, S Wyatt, C O'Connor… - International Journal …, 2015 - Taylor & Francis
It is well established that neuroinflammation is associated with the progression of many
neurodegenerative diseases, including Parkinson's disease (PD). Activated microglia and …

Neuroprotective potential of AAV-mediated NURR1 expression in a rat model of Parkinson's disease

J Mudannayake - 2015 - researchspace.auckland.ac.nz
Parkinson's disease (PD) is characterised by the progressive neurodegeneration of the
nigrostriatal dopaminergic neurons that results in motor deficits including bradykinesia …